Suppr超能文献

流感病毒神经氨酸酶中抑制剂结合情况的分析

Analysis of inhibitor binding in influenza virus neuraminidase.

作者信息

Smith B J, Colman P M, Von Itzstein M, Danylec B, Varghese J N

机构信息

Biomolecular Research Institute, Parkville, Victoria 3052, Australia.

出版信息

Protein Sci. 2001 Apr;10(4):689-96. doi: 10.1110/ps.41801.

Abstract

2,3-didehydro-2-deoxy-N:-acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C9 position in DANA and 4-amino-DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three-dimensional X-ray structure of the complexes of these ligands and NA was obtained to 1.4 A resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.

摘要

2,3-二脱氢-2-脱氧-N-乙酰神经氨酸(DANA)是流感病毒神经氨酸酶(NA)的过渡态类似物抑制剂。为了利用与活性位点中保守酸性基团增加的静电相互作用来改善抑制剂结合,将DANA和4-氨基-DANA中C9位的羟基用胺基取代,这显著降低了这两种化合物的抑制剂活性。获得了这些配体与NA复合物的三维X射线结构,分辨率为1.4埃,结果表明两种配体与DANA等构结合。对C4位铵离子几何结构的分析表明,当这些配体结合时,Glu119可能呈中性。结合能的计算分析表明,这种取代成功地增加了相互作用能;然而,所获得的能量增益不足以克服使与蛋白质接触的配体部分去溶剂化所需的能量。

相似文献

引用本文的文献

3
The making of a potent L-lactate transport inhibitor.一种强效L-乳酸转运抑制剂的制备
Commun Chem. 2021 Sep 6;4(1):128. doi: 10.1038/s42004-021-00564-5.
5
Antivirals Targeting the Neuraminidase.抗神经氨酸酶药物。
Cold Spring Harb Perspect Med. 2022 Jan 4;12(1):a038455. doi: 10.1101/cshperspect.a038455.

本文引用的文献

1
Carbocyclic Analogues of N-Acetyl-2,3-didehydro-2-deoxy-D-neuraminic Acid (Neu5Ac2en, DANA): Synthesis and Inhibition of Viral and Bacterial Neuraminidases.
Angew Chem Int Ed Engl. 1998 Jul 3;37(12):1732-1734. doi: 10.1002/(SICI)1521-3773(19980703)37:12<1732::AID-ANIE1732>3.0.CO;2-I.
2
Raster3D: photorealistic molecular graphics.Raster3D:逼真的分子图形。
Methods Enzymol. 1997;277:505-24. doi: 10.1016/s0076-6879(97)77028-9.
5
Effectiveness and role of zanamivir in the treatment of influenza infection.
Ann Med. 1999 Oct;31(5):313-7. doi: 10.3109/07853899908995897.
6
Zanamivir: a review of its use in influenza.扎那米韦:其在流感治疗中的应用综述
Drugs. 1999 Oct;58(4):761-84. doi: 10.2165/00003495-199958040-00016.
7
Zanamivir: a review of clinical safety.扎那米韦:临床安全性综述
Drug Saf. 1999 Oct;21(4):267-81. doi: 10.2165/00002018-199921040-00003.
8
Neuraminidase inhibitors as anti-influenza virus agents.神经氨酸酶抑制剂作为抗流感病毒药物。
Antivir Chem Chemother. 1999 Jul;10(4):141-54. doi: 10.1177/095632029901000401.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验